6P9

[2-(phenylamino)-1,4-phenylene]bis({4-[2-(pyrrolidin-1-yl)ethyl]piperidin-1-yl}methanone)

Created:	2016-05-18
Last modified:	2017-05-10

Find Related PDB Entry
1 entries where 6P9 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	94
Chiral Atom Count	0
Bond Count	99
Aromatic Bond Count	12

2D diagram of 6P9

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	[2-(phenylamino)-1,4-phenylene]bis({4-[2-(pyrrolidin-1-yl)ethyl]piperidin-1-yl}methanone)
Systematic Name (OpenEye OEToolkits)	[3-phenylazanyl-4-[4-(2-pyrrolidin-1-ylethyl)piperidin-1-yl]carbonyl-phenyl]-[4-(2-pyrrolidin-1-ylethyl)piperidin-1-yl]methanone
Formula	C₃₆ H₅₁ N₅ O₂
Molecular Weight	585.822
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C1CC(CCN1C(=O)c5c(Nc2ccccc2)cc(C(=O)N4CCC(CCN3CCCC3)CC4)cc5)CCN6CCCC6
SMILES	CACTVS	3.385	O=C(N1CC[CH](CCN2CCCC2)CC1)c3ccc(C(=O)N4CC[CH](CCN5CCCC5)CC4)c(Nc6ccccc6)c3
SMILES	OpenEye OEToolkits	2.0.4	c1ccc(cc1)Nc2cc(ccc2C(=O)N3CCC(CC3)CCN4CCCC4)C(=O)N5CCC(CC5)CCN6CCCC6
Canonical SMILES	CACTVS	3.385	O=C(N1CC[C@H](CCN2CCCC2)CC1)c3ccc(C(=O)N4CC[C@H](CCN5CCCC5)CC4)c(Nc6ccccc6)c3
Canonical SMILES	OpenEye OEToolkits	2.0.4	c1ccc(cc1)Nc2cc(ccc2C(=O)N3CCC(CC3)CCN4CCCC4)C(=O)N5CCC(CC5)CCN6CCCC6
InChI	InChI	1.03	InChI=1S/C36H51N5O2/c42-35(40-24-14-29(15-25-40)12-22-38-18-4-5-19-38)31-10-11-33(34(28-31)37-32-8-2-1-3-9-32)36(43)41-26-16-30(17-27-41)13-23-39-20-6-7-21-39/h1-3,8-11,28-30,37H,4-7,12-27H2
InChIKey	InChI	1.03	MJSAAVJPPGYWEY-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	126480585

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.